Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Burton

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
World Neurosurgery|February 11, 2018
National Trends for Reoperation in Older Patients with GlioblastomaYi-Ren Chen, Jon Sole, Beatrice Ugiliweneza, et al.
Journal of Neuro-Oncology|November 22, 2021
Stereotactic radiosurgery for melanoma brain metastases: dose-size response relationship in the era of immunotherapyMehran Yusuf, Abbas Rattani, Jeremy Gaskins, et al.
Journal of Neuro-Oncology|October 4, 2023
Risk of developing glioblastoma following non-CNS primary cancer: a SEER analysis between 2000 and 2018David Y A Dadey, Zachary A Medress, Mayur Sharma, et al.
Neuro-Oncology|January 31, 2006
Phase 1 study of erlotinib HCl alone and combined with temozolomide in patients with stable or recurrent malignant gliomaMichael D Prados, Kathleen R Lamborn, Susan Chang, et al.
CNS Oncology|February 10, 2022
Challenges of imaging interpretation to predict oligodendroglioma grade: a report from the Neuro-Oncology BranchOrwa Aboud, Ritu Shah, Elizabeth Vera, et al.
Future Oncology (London, England)|April 10, 2020
Temozolomide in secondary prevention of HER2-positive breast cancer brain metastasesAlexandra S Zimmer, Seth M Steinberg, Dee Dee Smart, et al.
Neuro-Oncology Practice|June 9, 2025
Implications of sociodemographic and clinical factors on symptom burden: Age-specific survivorship care in the primary central nervous system tumor populationKimberly R Robins, Tricia Kunst, Jennifer Reyes, et al.
Journal of Neuro-Oncology|February 26, 2020
The prevalence of altered body image in patients with primary brain tumors: an understudied populationLindsay Rowe, Elizabeth Vera, Alvina Acquaye, et al.
Neuro-Oncology Advances|February 23, 2023
Discovery of clinical and demographic determinants of symptom burden in primary brain tumor patients using network analysis and unsupervised clusteringBrandon H Bergsneider, Elizabeth Vera, Ophir Gal, et al.
Neuro-Oncology Practice|February 7, 2025
The COVID-19 pandemic experience for patients with central nervous system tumors: Differences in patient-reported outcomes and practice recommendationsAmanda L King, Kayla N Roche, Elizabeth Vera, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
World Neurosurgery|February 11, 2018
National Trends for Reoperation in Older Patients with GlioblastomaYi-Ren Chen, Jon Sole, Beatrice Ugiliweneza, et al.
Journal of Neuro-Oncology|November 22, 2021
Stereotactic radiosurgery for melanoma brain metastases: dose-size response relationship in the era of immunotherapyMehran Yusuf, Abbas Rattani, Jeremy Gaskins, et al.
Journal of Neuro-Oncology|October 4, 2023
Risk of developing glioblastoma following non-CNS primary cancer: a SEER analysis between 2000 and 2018David Y A Dadey, Zachary A Medress, Mayur Sharma, et al.
Neuro-Oncology|January 31, 2006
Phase 1 study of erlotinib HCl alone and combined with temozolomide in patients with stable or recurrent malignant gliomaMichael D Prados, Kathleen R Lamborn, Susan Chang, et al.
CNS Oncology|February 10, 2022
Challenges of imaging interpretation to predict oligodendroglioma grade: a report from the Neuro-Oncology BranchOrwa Aboud, Ritu Shah, Elizabeth Vera, et al.
Future Oncology (London, England)|April 10, 2020
Temozolomide in secondary prevention of HER2-positive breast cancer brain metastasesAlexandra S Zimmer, Seth M Steinberg, Dee Dee Smart, et al.
Neuro-Oncology Practice|June 9, 2025
Implications of sociodemographic and clinical factors on symptom burden: Age-specific survivorship care in the primary central nervous system tumor populationKimberly R Robins, Tricia Kunst, Jennifer Reyes, et al.
Journal of Neuro-Oncology|February 26, 2020
The prevalence of altered body image in patients with primary brain tumors: an understudied populationLindsay Rowe, Elizabeth Vera, Alvina Acquaye, et al.
Neuro-Oncology Advances|February 23, 2023
Discovery of clinical and demographic determinants of symptom burden in primary brain tumor patients using network analysis and unsupervised clusteringBrandon H Bergsneider, Elizabeth Vera, Ophir Gal, et al.
Neuro-Oncology Practice|February 7, 2025
The COVID-19 pandemic experience for patients with central nervous system tumors: Differences in patient-reported outcomes and practice recommendationsAmanda L King, Kayla N Roche, Elizabeth Vera, et al.
Pageof 5